BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Sean McCarthy will participate on a panel at the Charlotte Biotechnology Conference titled "Financing Successful Biotech Companies", on the campus of UNC-Charlotte.
News | 10. 12. 2007
